Insider Trading & Ownership - DHILLON PUNIT

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for DHILLON PUNIT
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-11-15
Sale
2024-11-19
9:20 pm
Skye Bioscience Inc.SKYEDHILLON PUNIT
Chief Executive Officer
82,910$4.9925$413,925339,166
(Indirect
Direct)
View
2023-08-29
Purchase(A)
2023-08-31
11:26 am
Skye Bioscience Inc.SKYEDHILLON PUNIT
Chief Executive Officer
881,000$0.0187$16,47530,272,724
(Indirect
Direct)
View
2023-08-29
Purchase
2023-08-29
6:39 pm
Skye Bioscience Inc.SKYEDHILLON PUNIT
Chief Executive Officer
881,000$0.0187$16,47543,807,874
(Direct)
View
2020-08-07
Purchase(M)
2020-08-11
2:53 pm
Emerald Bioscience Inc.EMBIDHILLON PUNIT
CEO
1,000,000$0.1$100,00010,200,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-10-28
Option Award
2024-10-30
8:31 pm
N/A
2034-10-27
Skye Bioscience Inc.SKYEDHILLON PUNIT
Chief Executive Officer
650,000$0650,000
(Direct)
View
2024-08-26
Other
2024-08-27
5:20 pm
N/A
N/A
Skye Bioscience Inc.SKYEDHILLON PUNIT
Chief Executive Officer
15,727$0437,803
(Direct)
View
2024-02-29
Option Award(A)
2024-03-04
06:13 am
N/A
2034-03-01
Skye Bioscience Inc.SKYEDHILLON PUNIT
Chief Executive Officer
225,000$0522,006
(Direct)
View
2024-02-29
Option Award
2024-03-01
6:24 pm
N/A
2034-03-01
Skye Bioscience Inc.SKYEDHILLON PUNIT
Chief Executive Officer
225,000$0522,006
(Direct)
View
2023-11-06
Option Award
2023-11-06
8:29 pm
N/A
2033-08-25
Skye Bioscience Inc.SKYEDHILLON PUNIT
Chief Executive Officer
215,856$0327,605
(Direct)
View
2023-08-28
Acquisition(A)
2023-08-31
11:26 am
N/A
N/A
Skye Bioscience Inc.SKYEDHILLON PUNIT
Chief Executive Officer
110,000$0.017130,272,724
(Direct)
View
2023-08-25
Option Award(A)
2023-08-31
11:26 am
N/A
2033-08-25
Skye Bioscience Inc.SKYEDHILLON PUNIT
Chief Executive Officer
22,530,460$030,272,724
(Direct)
View
2023-08-23
Acquisition(A)
2023-08-31
11:26 am
N/A
N/A
Skye Bioscience Inc.SKYEDHILLON PUNIT
Chief Executive Officer
9,000$0.011830,272,724
(Direct)
View
2023-08-28
Acquisition
2023-08-29
6:39 pm
N/A
N/A
Skye Bioscience Inc.SKYEDHILLON PUNIT
Chief Executive Officer
110,000$0.017143,807,874
(Direct)
View
2023-08-25
Option Award
2023-08-29
6:39 pm
N/A
2033-08-25
Skye Bioscience Inc.SKYEDHILLON PUNIT
Chief Executive Officer
22,530,460$043,807,874
(Direct)
View
2023-08-23
Acquisition
2023-08-29
6:39 pm
N/A
N/A
Skye Bioscience Inc.SKYEDHILLON PUNIT
Chief Executive Officer
9,000$0.011843,807,874
(Direct)
View
2022-11-10
Option Award
2022-11-15
1:41 pm
N/A
2024-04-03
Skye Bioscience Inc.SKYEDHILLON PUNIT
Chief Executive Officer
5,302,264$08,302,264
(Direct)
View
2022-11-10
Option Award
2022-11-10
9:54 pm
N/A
2032-11-10
Arch Therapeutics Inc.ARTHDHILLON PUNIT
Director
250,000$0250,000
(Direct)
View
2021-12-14
Option Award
2021-12-16
7:03 pm
N/A
2031-12-14
Skye Bioscience Inc.SKYEDHILLON PUNIT
Chief Executive Officer
5,090,000$06,090,000
(Direct)
View
2021-09-27
Option Award
2021-10-01
08:11 am
N/A
2031-09-26
Arch Therapeutics Inc.ARTHDHILLON PUNIT
Director
500,000$0500,000
(Direct)
View
2020-08-07
Option Award
2020-08-11
2:53 pm
N/A
N/A
Emerald Bioscience Inc.EMBIDHILLON PUNIT
CEO
9,000,000$010,200,000
(Direct)
View
(A) Indicate amendment filing.
(M) Indicate average unit share price adjusted based on the original filings.